| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 03/02/2004 | US6699691 Alcohol oxidase 1 regulatory nucleotide sequences for heterologous gene expression in yeast |
| 03/02/2004 | US6699672 Heparanase specific molecular probes and their use research and medical applications |
| 03/02/2004 | US6699660 Isolated nucleic acid identical to one expressed in response to seizure or ischemia |
| 03/02/2004 | US6699658 Yeast cell surface display of proteins and uses thereof |
| 03/02/2004 | US6699482 Leptospira rare outer membrane proteins |
| 03/02/2004 | US6698134 Proliferating cells contained in aqueous alkaline inorganic nutrient medium in lighted, temperature controlled, ventilated electrical appliance |
| 03/02/2004 | CA2149441C Activin receptor-like kinases, proteins having serine threonine kinase domains and their use |
| 03/01/2004 | WO2004078375A1 Additive for use in restoration of contaminated soil, ground water or sediment soil |
| 02/26/2004 | WO2004016802A2 Methods and apparatus for preparing and assaying biological samples to determine protein concentration |
| 02/26/2004 | WO2004016795A1 Methods for inducing targeted stimulation of meiotic recombination and kits for performing said methods |
| 02/26/2004 | WO2004016792A1 Novel expression vector suitable for expression of recombinant protein at low temperature |
| 02/26/2004 | WO2004016790A1 Novel n-acetylgalactosamine transferases and nucleic acids encoding the same |
| 02/26/2004 | WO2004016778A1 Improved methods of in vitro protein synthesis |
| 02/26/2004 | WO2004016771A1 Microorganism producing hyaluronic acid and purification method of hyaluronic acid |
| 02/26/2004 | WO2004016770A1 Biological leavening agent of carbon-process filter mud and its process for preparing active simgca feritlizer |
| 02/26/2004 | WO2004016743A2 Culturing anaplasma |
| 02/26/2004 | WO2004016740A2 Humanized rabbit antibodies |
| 02/26/2004 | WO2004016726A2 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms |
| 02/26/2004 | WO2004016283A2 Heteropolymeric compound comprising a scaffold, an adjuvant and an antigen, and its use |
| 02/26/2004 | WO2004016220A2 Apicomplexan pathways, inhibitiors, and drug delivery |
| 02/26/2004 | WO2004001054A3 Flocculation with divalent salt |
| 02/26/2004 | WO2004000369A3 Method of magnetically manipulating a cell with magnetisable particles |
| 02/26/2004 | WO2003102170A8 Strains of bordetella made deficient by means of genetic attenuation |
| 02/26/2004 | WO2003097817A9 Novel microorganism acidovorax temperans and uses therefor |
| 02/26/2004 | WO2003089614A3 Production of functional antibodies in filamentous fungi |
| 02/26/2004 | WO2003089589A3 Matrix analysis of gene expression in cells (magec) |
| 02/26/2004 | WO2003073982A3 Anti-interleukin-1 beta analogs |
| 02/26/2004 | WO2003068926A3 Over-expression of extremozyme genes in pseudomonads and closely related bacteria |
| 02/26/2004 | WO2003066815A3 Method for producing 2-hydroxyisobutyric acid and methacrylic acid from acetone cyanohydrin |
| 02/26/2004 | WO2003060071A3 Albumin fusion proteins |
| 02/26/2004 | WO2003057829A3 Methods of generating multispecific, multivalent agents from vh and vl domains |
| 02/26/2004 | WO2003054210B1 Regulated nucleic acid expression system |
| 02/26/2004 | WO2003054019A3 Therapeutic monoclonal anti-tirc7 antibodies for use in immune related and other diseases |
| 02/26/2004 | WO2003046156A3 Bacterial biomasses, protocol for obtaining same, and uses thereof for bacterization of soils and crop residues |
| 02/26/2004 | WO2003008449A8 Ntb-a, a surface molecule involved in natural killer cells activity |
| 02/26/2004 | WO2003006485A3 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 02/26/2004 | WO2003004611A3 Human olfactory nucleotide-gated ion channels |
| 02/26/2004 | WO2003002711A3 A NOVEL GROUP OF α-AMYLASES AND A METHOD FOR IDENTIFICATION AND PRODUCTION OF NOVEL α-AMYLASES |
| 02/26/2004 | WO2003002066A3 Glycosylated kinamycins and methods of making and using them |
| 02/26/2004 | WO2002103002A3 Gene associated with leishmania parasite virulence |
| 02/26/2004 | WO2002102973A3 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 02/26/2004 | WO2002101003A3 Stereoselective preparation of cyclic l-amino acids |
| 02/26/2004 | WO2002083869A3 Product and process for transformation of thraustochytriales microorganisms |
| 02/26/2004 | WO2002068600A3 Endogenous and non-endogenous versions of human g protein-coupled receptors |
| 02/26/2004 | WO2002066652A3 Ehrlichia ruminantium polypeptides, antigens, polynucleotides, and methods of use |
| 02/26/2004 | WO2002062204A3 Methods for diagnosing and treating heart disease |
| 02/26/2004 | WO2002051237A3 Helicobacter proteins, nucleic acids and uses thereof |
| 02/26/2004 | WO2002046418A3 Lipid-associated molecules |
| 02/26/2004 | WO2002046382A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 02/26/2004 | WO2002033089A3 Ixodes scapularis tissue factor pathway inhibitor |
| 02/26/2004 | WO2001057175A3 Methods and materials relating to neurotrimin-like polypeptides and polynucleotides |
| 02/26/2004 | US20040040062 Method for producing human lactoferrin in plant cell culture |
| 02/26/2004 | US20040040059 Pectinophora gossypiella (pink bollworm) bacillus thuringiensis toxin receptor BT-R2 |
| 02/26/2004 | US20040040049 Reduction in the formation of the complex in the presence of the candidate agent as compared with in the absence of candidate agent indicates the candidate agent inhibits the binding of LBP-2 to the LBP-2 binding molecule |
| 02/26/2004 | US20040039188 Systems and methods for the rapid isolation of nucleic acids |
| 02/26/2004 | US20040039185 Novel family member of inhibitor of apoptosis proteins |
| 02/26/2004 | US20040039184 Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 02/26/2004 | US20040039166 Newly identified polypeptides and polynucleotides encoding such polypeptides referred to as inhibitor of apoptosis proteins (IAPL-3); use in diagnosis and in identifying compounds that may be agonists, antagonists |
| 02/26/2004 | US20040038896 For diagnosis and therapy |
| 02/26/2004 | US20040038886 Chimeric cytoplasmic signalling molecules derived from cd137 |
| 02/26/2004 | US20040038879 For therapy and prophylaxis of infections such as bacterial, fungal, protozoan, and viral infections, particularly those caused by HIV viruses, pain, cancers, anorexia, bulimia, asthma, Parkinson's disease, acute heart failure |
| 02/26/2004 | US20040038877 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 02/26/2004 | US20040038869 Inhibitors of complement activation, their preparation and use |
| 02/26/2004 | US20040038855 Administering a compound which is a mammalian MCH1 receptor antagonist effective to treat the abnormality |
| 02/26/2004 | US20040038391 Amino acids factory |
| 02/26/2004 | US20040038382 Comprises genes encoding toluene-degrading enzymes having homology to Escherichia coli pyruvate formate lyase; waste treatment; pollution control |
| 02/26/2004 | US20040038381 Comprises genetically engineered strains of Pichia; mannosidases; glycoproteins; kits |
| 02/26/2004 | US20040038380 Bacterial strain of escherichia coli BKIIM B-3996 as the producer of L-threonine |
| 02/26/2004 | US20040038379 Probiotic strains from Lactobacillus salivarius and antimicrobial agents obtained therefrom |
| 02/26/2004 | US20040038374 Method for accessing microbial diversity |
| 02/26/2004 | US20040038371 Aminopeptidase |
| 02/26/2004 | US20040038370 Claudin polypeptides |
| 02/26/2004 | US20040038368 Improved pH stability; for washing and/or dishwashing detergents |
| 02/26/2004 | US20040038367 Which cleaves the second beta-glucoside linkage of xyloglucans; isolated from Geotrichum species |
| 02/26/2004 | US20040038366 Improved heat resistance; genetic engineering |
| 02/26/2004 | US20040038364 Such as snake venom proteases; anticoagulants |
| 02/26/2004 | US20040038363 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 02/26/2004 | US20040038362 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 02/26/2004 | US20040038361 Novel protein kinase (NPK-110) |
| 02/26/2004 | US20040038357 Producing a fagopyritol, an insulin mediator, an insulin mediator analogue, an insulin mediator homologue, or an insulin mediator inhibitor |
| 02/26/2004 | US20040038356 Method and kit for discontinuous density gradient centrifugation to separate a minimum of two substances in a sample; method and kit use is made of colloidal density media and low-density solutions |
| 02/26/2004 | US20040038353 Production of a taxanes by cloning a DNA sequence comprising a taxane synthesis pathway, making a DNA construct where the DNA sequence is under control of regulatory elements, introducing said DNA construct into a host cell, recovering the taxane |
| 02/26/2004 | US20040038352 Method for fermentative production of amino acids and amino acid derivatives of the phosphoglycerate family |
| 02/26/2004 | US20040038351 By reacting glyceraldehyde 3-phosphate and acetaldehyde in the presence of either a microorganism itself which contains 2-deoxyribose-5- phosphate aldolase but substantially no phosphatase or the enzyme derived from the microorganism |
| 02/26/2004 | US20040038342 Novel strain of streptomyces sp. and a process for the preparation of an alkaline protease inhibitor |
| 02/26/2004 | US20040038341 Chimeric human-type vascular endothelial cell growth factor |
| 02/26/2004 | US20040038340 Used in the processing of fermented foods by imparting an improved texture and flavor, and/or a higher content in aroma compounds; mutant has a mutation impairing the regulation of a carbon catabolite repression (CCR) mechanism |
| 02/26/2004 | US20040038339 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex |
| 02/26/2004 | US20040038334 Thermal tolerant avicelase from acidothermus cellulolyticus |
| 02/26/2004 | US20040038330 Inhibitor of hepatitis B and HIV activity |
| 02/26/2004 | US20040038328 Assay for melanogenesis |
| 02/26/2004 | US20040038298 Protein fragment complementation assays for the detection of biological or drug interactions |
| 02/26/2004 | US20040038290 Comprises nucleotide sequences coding heat resistant polymerase for use as DNA replication/amplification tool in genetic engineering |
| 02/26/2004 | US20040038289 Nucleic acid encoding bacillus stearothermophilus delta polymerase subunit |
| 02/26/2004 | US20040038288 Human protein C Polypeptide |
| 02/26/2004 | US20040038286 Comprises nucleotide sequences coding oxalyl-CoA decarboxylase for diagnosis and treatment of kidney, lipid malabsorptive and inflammatory bowel diseases |
| 02/26/2004 | US20040038284 Using replication error phenotype (RER) to classify and prognose tumor disorders; immunoassay |
| 02/26/2004 | US20040038279 Comprises ubiquitin conjugating enzyme for diagnosis, prevention and treatment of cell proliferative, immunological, neurological, and reproductive disorders |
| 02/26/2004 | US20040038275 Human frezzled-like protein |
| 02/26/2004 | US20040038271 Novel C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |